Related Experiment Video
Updated: Oct 2, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Where patients with cancer die in South Australia, 1990-1999: a population-based review
R W Hunt1, B S Fazekas, C G Luke
1Southern Adelaide Palliative Services, SA. roger.hunt@rgh.sa.gov.au
Objective:
To determine the place of death of South Australians who die of cancer.
Design:
A population-based, cross-sectional study of data from the South Australian Cancer Registry.
Participants:
29,230 patients with cancer dying in 1990-1999.
Main Outcome Measures:
Place of death; patient demography; year of death; survival from diagnosis; and type of cancer.
Results:
25.0% of patients died in a metropolitan public hospital, 19.9% in a hospice, 16.9% in a country hospital, 15.8% at a private residence, 12.7% in a metropolitan private hospital, and 9.7% in a nursing home. Although the change in place of death was not marked, multivariate logistic regression showed a secular trend away from metropolitan public hospitals towards metropolitan private hospitals and, in 1998-1999, towards nursing homes. Patients dying of cancer in a metropolitan public hospital were more likely to be younger, males, born outside Australia, and residents of lower socioeconomic areas of Adelaide. They were also more likely to have died within three months of diagnosis, and to have a haematological malignancy or a cancer of the upper digestive tract, lung or female breast. In contrast, patients dying at a private residence tended to be under 70 years and comprise longer-term survivors. Country residents were less likely than Adelaide residents to die in a hospice.
Conclusion:
The proportion of patients dying in different settings have health service implications. The relatively low use of hospice facilities by country patients may reflect differences in access to hospice facilities.
Related Concept Videos
Cancer Survival Analysis
Kaplan-Meier Approach
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Comparing the Survival Analysis of Two or More Groups